Dividend income
6.81 $
Earnings per share
2.95 $
Price/earnings (P/E)
5.52 $
Capitalization
4.16 billion $
Sector
Healthcare
Shares outstanding
255.57 million
Capitalization
4.16 billion $
Price/earnings (P/E)
5.52 $
Earnings per share
2.95 $
Dividend rate
1.12 $
Dividend income
6.81 $
Organon & Co. - is a global pharmaceutical company operating in womens health, biosimilars and popular brands. The company develops contraceptives and fertility drugs, immunological products and cancer drugs, as well as a wide range of products in the fields of cardiovascular, respiratory, dermatological and non-opioid therapies. Registered in 2020.